Dr Lee Shing Fung is an Associate Consultant at the National University Cancer Institute, Singapore (NCIS), serving within the Department of Radiation Oncology. His work contributes to the provision of radiotherapy services across the NUHS and NHG clusters. He accomplished his medical training at the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKU) in 2010, followed by his appointment as a Fellow of the Royal College of Radiologists (UK) in 2015.
Dr Lee's clinical practice focuses on lymphoma, lower gastrointestinal tract cancers, central nervous system cancers, and gynaecological cancers. His research activities centre around enhancing the synergy of radiotherapy with systemic therapies, which includes traditional chemotherapy and newer targeted agents, particularly in managing gastrointestinal tract malignancies, lymphoma, and central nervous system cancers.
He is actively involved in large-scale data studies founded on population-based databases. Collaborating with Dr Miguel Fernandez from the London School of Hygiene and Medicine, UK, Dr Lee is currently investigating the causal inference of various agents on cancer risk and outcomes.
Parallel to these, Dr Lee holds a keen interest in the development of innovative techniques or regimens for radiotherapy delivery, as well as the assessment of radiation effects on normal tissues. His projects include evaluating the application of novel palliative radiotherapy dose-fractionation for advanced lung cancer patients and studying changes in physiological functions and blood counts following radiation therapy for lymphoma and gastrointestinal tract tumours.
Dr Lee has contributed to the scientific community by publishing numerous papers in esteemed peer-reviewed medical journals, adding to the understanding and management of various cancer types.
